<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>OPUS 4 Latest Documents RSS Feed</title>
    <description>Latest documents</description>
    <link>http://publikationen.ub.uni-frankfurt.de/index/index/</link>
    <pubDate>Wed, 11 Oct 2006 08:38:46 +0100</pubDate>
    <lastBuildDate>Wed, 11 Oct 2006 08:38:46 +0100</lastBuildDate>
    <item>
      <title>Enzymatic and antisense effects of a specific anti-Ki-ras ribozyme in vitro and in cell culture</title>
      <link>http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/2134</link>
      <description>Due to their mode of action, ribozymes show antisense effects in addition to their specific cleavage activity. In the present study we investigated whether a hammerhead ribozyme is capable of cleaving mutated Ki-ras mRNA in a pancreatic carcinoma cell line and whether antisense effects contribute to the activity of the ribozyme. A 2[prime]-O-allyl modified hammerhead ribozyme was designed to cleave specifically the mutated form of the Ki-ras mRNA (GUU motif in codon 12). The activity was monitored by RT-PCR on Ki-ras RNA expression by determination of the relative amount of wild type to mutant Ki-ras mRNA, by 5-bromo-2[prime]-deoxy-uridine incorporation on cell proliferation and by colony formation in soft agar on malignancy in the human pancreatic adenocarcinoma cell line CFPAC-1, which is heterozygous for the Ki-ras mutation. A catalytically inactive ribozyme was used as control to differentiate between antisense and cleavage activity and a ribozyme with random guide sequences as negative control. The catalytically active anti-Ki-ras ribozyme was at least 2-fold more potent in decreasing cellular Ki-ras mRNA levels, inhibiting cell proliferation and colony formation in soft agar than the catalytically inactive ribozyme. The catalytically active anti-Ki-ras ribozyme, but not the catalytically inactive or random ribozyme, increased the ratio of wild type to mutated Ki-ras mRNA in CFPAC-1 cells. In conclusion, both cleavage activity and antisense effects contribute to the activity of the catalytically active anti-Ki-ras hammerhead ribozyme. Specific ribozymes might be useful in the treatment of pancreatic carcinomas containing an oncogenic GTT mutation in codon 12 of the Ki-ras gene.</description>
      <author>Claudio Detlef Giannini; W. Kurt Roth; Albrecht Piiper; Stefan Zeuzem</author>
      <category>article</category>
      <guid>http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/2134</guid>
      <pubDate>Fri, 10 Nov 2006 08:38:46 +0100</pubDate>
    </item>
  </channel>
</rss>
